Trading Signals: AIM Stock Price Prediction and Forecast (Tue. Jul. 28, 2009 - Mon. Mar. 9, 2020)(AIM ImmunoTech Inc)
| AIM latest price $316.8000 (7.14%) ($295.6800 - $324.7200) on Mon. Jan. 4, 2010. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 7.7% (three month average) | | RSI | 53 | | Latest Price | $316.8000(7.14%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | AIM advances 0.2% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support AIM advance at 0% a week (0% probability)
EWP(1%) EWG(-0%) EWI(-0%) GLD(0%) EWJ(-1%) | | Factors Impacting AIM price | AIM will decline at least -3.85% in a week (0% probabilities).
XLU(-7%) XLP(-6%) TLT(-4%) TIP(-4%) XLY(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -3.85% (StdDev 7.7%) | | Hourly BBV | 0 () | | Intraday Trend | 4.3% | | | | | |
|
| 1 - 5 Day Possible Target | $309.48(-2.31%) | | 5 Day Moving Average | $311.52(1.69%) | | 10 Day Moving Average | $313.09(1.18%) | | 20 Day Moving Average | $314.97(0.58%) | | To recent high | -69.2% | | To recent low | 9.1% | | Market Cap | $10.851b | | | | | | |
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL. |